Dr. Markman Discusses Diagnostic Molecular Testing

Maurie Markman, MD, senior vice president for Clinical Affairs, National Director for Medical Oncology, Cancer Treatment Centers of America, Eastern Regional Medical Center, explains the shift in diagnostic tools towards molecular testing.

Cancer treatment is moving towards a molecular diagnostic paradigm. Various forms of diagnostic testing have been used for quite some time but only recently the type of testing has become more molecularly based. Very detailed molecular profiles of each individual's cancer can help determine a cure, spread of the disease, and the efficacy of therapy.

Markman believes that molecular diagnostics are revolutionary and will bring about more changes in cancer care than the past 100 years of cancer management advances.